S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME

• D. Noerenberg,
• F. Briest,
• C. Hennch,
• K. Yoshida,
• J. Nimo,
• R. Hablesreiter,
• Y. Takeuchi,
• D. Sasca,
• H. Ueno,
• L. Mansouri,
• Y. Inoue,
• L. Wiegand,
• A. M. Staiger,
• B. Casadei,
• M. Ziepert,
• F. Asmar,
• P. Korkolopoulou,
• M. Kirchner,
• P. Mertins,
• J. Weiner,
• E. Toth,
• T. Weber,
• A. Warth,
• T. Schneider,
• R.-M. Amini,
• W. Klapper,
• M. Hummel,
• V. Poeschel,
• G. Kanellis,
• A. Rosenwald,
• G. Held,
• E. Campo,
• K. Stamatopoulos,
• I. Anagnostopoulos,
• L. Bullinger,
• N. Goldschmidt,
• P. L. Zinzani,
• C. Bödor,
• R. Rosenquist,
• T. P. Vassilakopoulos,
• G. Ott,
• S. Ogawa,
• F. Damm

Affiliations

D. Noerenberg

1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

F. Briest

1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

C. Hennch

1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

K. Yoshida

2 Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

J. Nimo

1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

R. Hablesreiter

1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Y. Takeuchi

2 Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

D. Sasca

4 Department of Hematology, Oncology, and Pulmonary Medicine, University Medical Center, Johannes Gutenberg-University, Mainz, Germany

H. Ueno

2 Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

L. Mansouri

5 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

Y. Inoue

2 Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

L. Wiegand

1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

A. M. Staiger

6 Department of Clinical Pathology, Robert-Bosch-Krankenhaus

B. Casadei

8 Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna

M. Ziepert

10 Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany

F. Asmar

11 Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

P. Korkolopoulou

12 First Department of Pathology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece

M. Kirchner

13 Core Unit Proteomics, Berlin Institute of Health, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine

P. Mertins

13 Core Unit Proteomics, Berlin Institute of Health, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine

J. Weiner

14 Core Unit Bioinformatics, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany

E. Toth

15 National Institute of Oncology, Budapest, Hungary

T. Weber

16 Department of Internal Medicine IV, Haematology and Oncology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle

A. Warth

17 Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany

T. Schneider

18 National Institute of Oncology, Budapest, Hungary

R.-M. Amini

19 Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden

W. Klapper

20 Department of Pathology, Hematopathology Section and Lymph Node Registry, Universitätsklinikum Schleswig-Holstein, Kiel

M. Hummel

21 Department of Pathology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin

V. Poeschel

23 Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany

G. Kanellis

24 Department of Hematopathology, Evangelismos General Hospital, Athens, Greece

A. Rosenwald

25 Institute of Pathology, University of Würzburg and Comprehensive Cancer Center (CCC) Mainfranken, Würzburg

G. Held

23 Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany

E. Campo

27 Centro de Investigacion Biomedica en Red en Oncologia (CIBERONC), Madrid

K. Stamatopoulos

5 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

I. Anagnostopoulos

21 Department of Pathology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin

L. Bullinger

1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

N. Goldschmidt

31 Hadassah-Hebrew University Medical Center, Jerusalem, Israel

P. L. Zinzani

9 Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy

C. Bödor

33 HCEMM-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary

R. Rosenquist

5 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

T. P. Vassilakopoulos

35 Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece

G. Ott

6 Department of Clinical Pathology, Robert-Bosch-Krankenhaus

S. Ogawa

2 Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

F. Damm

1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany